[HTML][HTML] Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

V Ambrosini, J Kunikowska, E Baudin, L Bodei… - European journal of …, 2021 - Elsevier
Nuclear medicine plays an increasingly important role in the management neuroendocrine
neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission …

Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review …

S Han, CH Suh, S Woo, YJ Kim… - Journal of Nuclear …, 2019 - Soc Nuclear Med
We performed a systematic review and metaanalysis of the performance of 68Ga-DOTA–
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …

European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …

Imaging of pheochromocytoma and paraganglioma

JA Carrasquillo, CC Chen, A Jha, A Ling… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Imaging plays a critical role in the management of pheochromocytomas and
paragangliomas and often guides treatment. The discovery of susceptibility genes …

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

D Taïeb, HJ Timmers, E Hindié, BA Guillet… - European journal of …, 2012 - Springer
Purpose Radionuclide imaging of phaeochromocytomas (PCCs) and paragangliomas
(PGLs) involves various functional imaging techniques and approaches for accurate …

68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI

I Janssen, CC Chen, D Taieb, NJ Patronas… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Pheochromocytomas/paragangliomas overexpress somatostatin receptors, and recent
studies have already shown excellent results in the localization of sympathetic succinate …

[HTML][HTML] PET molecular imaging: a holistic review of current practice and emerging perspectives for diagnosis, therapeutic evaluation and prognosis in clinical …

V Duclos, A Iep, L Gomez, L Goldfarb… - International journal of …, 2021 - mdpi.com
PET/CT molecular imaging has been imposed in clinical oncological practice over the past
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …

Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma in SDHx Mutation Carriers: A Multicenter Prospective Study from the PGL.EVA …

AP Gimenez-Roqueplo, A Caumont-Prim… - The Journal of …, 2013 - academic.oup.com
Context: Recommendations have not been established concerning imaging to screen SDHx
mutation carriers for paraganglioma and pheochromocytoma. Objective: Our objective was …

[HTML][HTML] PET with different radiopharmaceuticals in neuroendocrine neoplasms: An umbrella review of published meta-analyses

G Treglia, R Sadeghi, F Giovinazzo, F Galiandro… - Cancers, 2021 - mdpi.com
Simple Summary Functional imaging methods and, in particular, positron emission
tomography (PET) using several radiopharmaceuticals may play a pivotal role in patients …